Clorox Co /De/ (CLX) Stock Price & Analysis
Clorox Co /De/ (CLX) rose 1.87% to USD 95.55 as of July 25, 2026 at 03:01 UTC, according to Nexqual real-time market data.
CLX last closed at USD 93.8; the session ranged USD 93.45–96.03 on volume of 1,198,916 shares. Market capitalization is —, with a 52-week range of USD 84.7–131.86 (NYQ). Source: Nexqual, July 25, 2026 at 03:01 UTC.
Key Statistics (as of July 25, 2026 at 03:01 UTC)
| Price | USD 95.55 |
|---|---|
| Change | ▲ 1.87% (up) |
| Previous Close | USD 93.8 |
| Open | USD 94.21 |
| Day Range | USD 93.45 – 96.03 |
| 52-Week Range | USD 84.7 – 131.86 |
| Volume | 1,198,916 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CLX)
Nexqual's technical model rates CLX "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 03:01 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.16 (neutral) |
| vs SMA50 | Above (USD 94.82) |
| MACD | 0.06 (positive) |
Analyst Ratings (CLX)
Wall Street analysts rate CLX "Hold" based on 17 analysts, with a mean price target of USD 103.94 (range USD 77–155), per Nexqual as of July 25, 2026 at 03:01 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 103.94 |
| High Target | USD 155 |
| Low Target | USD 77 |
| Buy / Hold / Sell | 2 / 13 / 4 |
Earnings (CLX)
| Next Earnings Date | 2026-08-03 |
|---|---|
| EPS Estimate | USD 1.65 |
| Revenue Estimate | $1.91B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.64 vs est 1.54 ▲ beat |
| 2025-12-31 | USD 1.39 vs est 1.43 ▼ miss |
| 2025-09-30 | USD 0.85 vs est 0.78 ▲ beat |
| 2025-06-30 | USD 2.87 vs est 2.21 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Financials & Fundamentals (CLX)
| Total Revenue | $6.76B |
|---|---|
| Revenue Growth (YoY) | +0.10% |
| Gross Margin | +43.85% |
| Operating Margin | +17.01% |
| Profit Margin | +11.18% |
| ROE | +546.10% |
| Debt / Equity | 4,876.09 |
| Current Ratio | 0.84 |
| Total Cash | $1.19B |
| Total Debt | $4.49B |
| Free Cash Flow | $62.75M |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Financial Health Score (CLX)
Nexqual rates Clorox Co /De/'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:01 UTC.
| Growth | Mixed — Revenue +0.1% YoY (latest Q), slow |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 17% |
| Balance Sheet | Critical — $1.19B cash vs $4.49B debt |
| Cash Flow | Mixed — FCF $63M, slim 0.9% margin |
| Efficiency | Strong — ROE 546%, ROA 11.0% |
Ownership (CLX)
| Insider Ownership | +0.72% |
|---|---|
| Institutional Ownership | +86.35% |
| Float | 120.51M |
| Short % of Float | +10.80% |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
Leadership (CLX)
Clorox Co /De/ is led by Linda J. Rendle (age 47), CEO & Chairman, per Nexqual as of July 25, 2026 at 03:01 UTC.
| CEO & Chairman | Linda J. Rendle (age 47) |
|---|---|
| Executive VP & CFO | Luc Bellet (age 46) |
| Executive VP & COO | Chris T. Hyder (age 49) |
| Vice President of Investor Relations | Lisah Burhan |
| Senior VP & Chief Marketing Officer | Eric Sean Schwartz (age 52) |
Major Backers & Investors (CLX)
Notable institutional backers of Clorox Co /De/ include Invesco, Van Eck Associates Corporation, Morgan Stanley, according to Nexqual as of July 25, 2026 at 03:01 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 5.54% |
| Van Eck Associates Corporation | 2.66% |
| Morgan Stanley | 2.25% |
| VanEck ETF Trust-VanEck Morningstar Wide Moat ETF | 2.23% |
| ProShares Trust-ProShares S&P 500 Dividend Aristocrats ETF | 1.34% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.76% |
| BlackRock | 9.73% |
| State Street | 6.83% |
| Geode Capital | 2.67% |
| Northern Trust | 1.32% |
Source: Nexqual, July 25, 2026 at 03:01 UTC.
From Clorox Co /De/'s Latest SEC 10-K Filing (filed 2025-08-08)
Key Strengths & Strategy (as disclosed to the SEC)
- The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro ™ and Clorox Healthcare ® brand names.
- The Company also launched numerous innovations and new products in fiscal year 2025, including seven new Hidden Valley Ranch flavors, new scent options for Scentiva Bleach and Poett Multi-Purpose Cleaner, Burt's Bees Tinted Boosted Lip Balm and Rescue Lip Relief, Ever Clean Senior Cat Litter as well as Fresh Step Heavy Duty Litter, Kingsford Beercoal charcoal briquettes and the Brita Plus System.
- The ERP system implementation, expected to be completed in the U.S. during fiscal year 2026, has required and will continue to require investment of personnel and financial resources to support post-implementation efforts and system functionality.
Partnerships
- In February 2025, the Company announced that the Venture Agreement with The Procter & Gamble Company (P&G) for the Company's Glad bags and wraps business will wind down by January 31, 2026.
- In connection with its strategy, the Company expects to continue to seek acquisition, joint venture and investment opportunities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KMB | Kimberly-Clark Corporation | USD 109.7 | ▲ 0.75% |
| CL | Colgate-Palmolive Company | USD 90.75 | ▼ 0.96% |
| GIS | General Mills, Inc. | USD 36.03 | ▼ 2.38% |
| MKC | McCormick & Company, Incorporat | USD 49.96 | ▼ 3.96% |
| HRL | Hormel Foods Corporation | USD 25.31 | ▲ 0.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:01 UTC. This page is informational and not investment advice.